Global Endocrine Testing Market to be Worth USD 2.03 billion by 2019

Endocrine Testing MarketThe endocrine system and overview of endocrine testing

The endocrine system is comprised of endocrine glands as well as secretor organs that are responsible for releasing hormones into the blood stream directly. The proper functioning of the endocrine system is central to the regulation of various important body mechanisms such as emotional and sexual development, growth, as well as metabolism. The endocrine system also enables the body to handle stress as well as certain other cellular mechanisms by working in sync with the nervous system.

Browse full report with TOC:http://www.transparencymarketresearch.com/endocrine-testing-market.html

Hormones are often termed as the ‘chemical messengers’ of the body. They relay information and instructions from one cell set in the body to another. However, hormones can only ‘communicate’ with or act on body cells that feature the genetic programming to receive this information and instructions, and respond to it.

The ideal level of hormones in the body can sometimes change because of factors such as a change in the mineral level or level of body fluids, besides other factors such as infection and stress. It is possible to assess the exact hormone levels in the body by performing various types of endocrine tests.

The significance of endocrine tests

A surge or fall in hormone levels in the body can be accurately determined by endocrine testing market. Through these tests, it is possible to ascertain both hyposecretion as well as hypersecretion of hormones into the blood. An imbalance in hormones could be the cause of various endocrine-related disorders such as diabetes and sexual dysfunction among others.

As the number of people suffering from obesity, diabetes and infertility rise worldwide, it has paved the way for the growth of endocrine test kits. The growing acceptance of the use of such kits has to a certain extent contributed to this growth too.

In addition to endocrine test kits, the market has been introduced to various diagnostic platforms that are based on advanced technologies that have made testing more convenient and rapid. A growing healthcare awareness among people worldwide is yet another factor responsible for propelling growth in this market.

At the same time, there prevail certain market restraints such as complicated and rigid reimbursement policies and high development costs. These factors collectively hamper the ideal growth of the global endocrine testing market.

Growth sectors within the Endocrine Testing Market

Endocrine tests continue to remain instrumental in detecting abnormal hormone levels in the blood stream. Within the endocrine tests market, the segment that is likely to witness the highest growth up to 2019 is that of insulin tests primarily driven by the growing incidence of diabetes among people worldwide. The International Diabetes Federation (IDF) estimates that the number of diabetics in the world will reach 592 million by 2035. Reports also show that approximately 80% of those suffering from diabetes live in nations that are classified as having low or middle income.

The following tests constituted the largest markets within the endocrine tests sector:

  • Insulin tests are expected to record the highest growth rate during the forecast period as the global incidence of diabetes grows
  • Tests for thyroid-stimulating hormones are likely to occupy the second highest growth rate over the period of the forecast as thyroid disorders rise and their connection with cardiovascular disorders emerges strongly
  • The third position is expected to be occupied by follicle stimulating hormone tests
  • The fourth position within the endocrine tests market is expected to be held by human chorionic Gonadotropin test

The demand for diagnostic technologies is expected to grow at varying rates. The fastest growing among these is expected to be the tandem mass spectrometry segment, followed by immunoassays and sensor technologies. However, the market for these test types could be hampered by their high costs and the considerable expenses involved in R&D.

Browse full PDF with TOC: Endocrine Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Asia-Pacific is expected to emerge as the fastest growing region for the Endocrine Tests market over the forecast period, because of factors such as growing awareness of healthcare, large patient pool, a growing disposable income and a healthy flow of investments by key market players.

Advertisements

Tablet PC Market – Global Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018

Tablet PC MarketAccording to a new market report published by Transparency Market Research ”Tablet PC Market – U.S. Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018” the tablet PC shipment in the U.S. was 34.2 million units in 2012 and is expected to grow to 71.6 million units by 2018, at a CAGR of 13.1% from 2012 to 2018. In 2010, iOS based tablet PCs held the largest share, accounting for more than 80% of the overall U.S. tablet PC market. However, Android based tablet PC shipment is expected to surpass the shipment of iOS based tablet PCs by 2017.

Browse the full report with TOC: http://www.transparencymarketresearch.com/tablet-pc.html

The U.S. tablet PC market is mainly driven by the growing demand from consumers for technologically advanced products. Moreover, smaller size compared to laptops, better battery life, and multi-tasking ability enables the use of tablet PCs in number of applications. In addition, there is growing demand for tablet PCs, especially from business enterprises as these devices are adapted for business software such as CRM, business intelligence and dashboards.

The study provides assessment of the U.S. tablet PC market based on intended use, screen size, interface (operating platform and user interface) and retail channel. In terms of screen size, tablet PCs with screen size ranging between 9.6″ and 11″ is the largest selling segment, with more than 25 million tablet PCs sold in 2012 in the U.S. Despite being the largest segment, the share of tablet PCs in this category is decreasing considerably with the growing popularity of tablet PCs having smaller screen size of 8 inch and below.

Tablet PCs in the U.S. has higher traction from individual customers who buy the product for their personal use, whereas the business and corporate use segment still has comparatively lower penetration. However, with the fast growing mobile workforce in the U.S., the corporate use segment is expected to be the fastest growing end use segment at a CAGR of 18.1% from 2012 to 2018.

The sale of tablet PCs through internet was high initially since the first tablet – iPad was available for sale primarily on the company website and few selective retail outlets. With the introduction of new tablet PCs by different manufacturers, the sale of tablets through retail outlets, especially mass retailers and specialty stores is expected to grow rapidly in the near future.

Browse full PDF with TOC: Tablet PC Market – Global Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018

There is variance in price with regards to intended use of tablet PCs. The overall average selling price (ASP) of tablet computers bought for business and corporate use intent is computed to be higher as compared to tablets bought for personal use intent. The higher ASP of business and corporate intent devices is largely due to the need of better processing speed and larger data storage capacities.

With the introduction of the first modern tablet – an iPad from Apple, the tablet PCs market in the U.S. begun to surface and gain ground. It created competition among the major desktop and laptop PC manufacturers who set out to obtain advantage of early movers in the U.S. market. Initially, Apple with its iOS dominated the U.S. tablet PCs market; however, Android based tablet PCs are expected to take over Apple’s share in the coming years.

This research report will provide complete insights on the U.S. tablet PC market and explain the current trends and factors responsible for driving the market growth. The study will prove to be helpful for emerging players to know about the growth strategies implemented by existing players and help existing players in strategic planning.

The world has seen aggressive competition among tablet PC manufacturers after the launch of iPad from Apple. Within five months of the release of iPad, Samsung launched its Samsung Galaxy Tab to compete with Apple. Since then, the tablet PC manufacturing industry has seen the emergence of numerous players. Most tablet manufacturers such as Asus, HP, and Lenovo among others released their models of tablet PCs in quick successions, but none of them could surpass Apple’s share.

U.S. Tablet PC Market 

  • Unit sales and selling price by intended use
    • Personal use
    • BYOD (Bring your own device)
    • Business use
    • Corporate use
    • Professional use
  • By platform
    • Unit sales and selling price by platform
      • iOS
      • Blackberry
      • Windows
      • Android
      • Others
  • By user interface
    • Command line interface
    • Graphic user interface
    • Auditory interface
  • Unit sales and selling price by screen size
    • Below 8
    • 8” to 9.5”
    • 9.6” to 11”
    • 11.1” and above
  • By distribution channel
    • Store based
      • Mass retailers
      • Specialty stores
      • Distributors
      • Others
  • Non-store based
    • Internet
    • Teleshopping
  • Tablet PC Accessories
    • Chargers
    • AV cables
    • Key board and docking stations
    • Screen protectors
    • Case and covers
    • Cradle/Stand
    • Stylus
    • Reading lights
    • Others

Biopreservation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

biopreservation marketAccording to a new market report published by Transparency Market Research Biopreservation Market (Product Types – Equipment, LIMS, and Media; Applications – Regenerative Medicine, Biobanking, and Drug Discovery) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019,theglobal biopreservation market was valued at USD 1.95billion in 2012 and is expected to reach a value of USD 5.74 billion in 2019, growing at a CAGR of 16.7% from 2013 to 2019.

Browse Biopreservation Market Report with Full TOC: http://www.transparencymarketresearch.com/biopreservation-market.html

Extensive undertaking of biomedical research for new drugs and therapies will be one of the major factors responsible for growth of the global biopreservation market. Use of stem cells, tissues, plasma and DNA in the research sector also requires adequate storage facilities to accommodate the growing number of samples, while also maintaining their stability. Increase in sample size will lead to rise in demand for equipment such as freezer, refrigerator, liquid nitrogen and consumables, along with media and laboratory information management systems (LIMS).In addition, increase in funding aimed at boosting the capacity for sample storage by the government as well as private institutions will expedite the introduction of new biopreservation facilities and hence will drive growth of the overall market. Other driving factors include rising incidences of cardiovascular, orthopedic, oncological, autoimmune and infectious diseases, rising population awareness and increase in the number of individual sample contributions.

The global biopreservation market by product type was dominated by the equipment segment with a market share of approximately 82% in 2012,on account of thehigh cost and demand from biobanks and in-house preservation facilities of pharmaceutical and biotechnology companies. Increase in the sample size will also result in the need for capacity expansion and so will lead to increase in demand for biopreservation equipment. However, the global market for biopreservation consumables will be the fastest growing product segment. Factors such as increased research and transnational activities will have a high demand for biological samples, which would also increase the demand for media solutions. The home-brew media segment held the majority share of over 72%in the total market for biopreservation media in 2012.

Browse full PDF with TOC: Biopreservation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The global biopreservation market by applications was dominated by the biobanking segment with a market share of approximately 72% in 2012 on account of the high demand and usage of equipment, media and LIMS in this segment. Establishment of new biobanks during the forecast period will be one of the major growth factors for the biobanking application segment.However, the global regenerative medicine market for biopreservation will be the fastest growing application segment. A factor such as high prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cardiac disorders and tumors is driving the regenerative medicine market which will result in increased demand for biopreservation media and equipment.

download-pdf

North America dominated the biopreservation market in 2012 and is expected to maintain its position till 2019. However, the Asia-Pacific market is estimated to grow at a faster CAGR of 19.6% from 2013 to 2019, due to increase in biobanking and research activities in the region. The European market is expected to grow at a fairly higher rate than North America,on account of the constantly improving infrastructure, regulatory framework and new biobanking projects, especially in the Eastern European region.

Some of the key players in the global biopreservation market include Thermo Fisher Scientific Inc., VWR International LLC, BioLife Solutions Inc., BioCision LLC, Biomatrica Inc., Qiagen, LABVANTAGE Solutions Inc. and Panasonic Corporation.

The global biopreservation market is segmented as follows:
 
Biopreservation Market, by Product Type
  • Equipment
    • Freezers
    • Refrigerators
    • Liquid Nitrogen (LN2) Tanks
    • Consumables
  • Laboratory Information Management Systems (LIMS)
  • Media
    • Home-brew Media
    • Pre-formulated Media
Biopreservation Market, by Application
  • Regenerative Medicine
  • Biobanking
  • Drug Discovery
Biopreservation Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Cord Blood Banking Services Market is Expected to Reach USD 15.2 Billion Globally in 2019: Transparency Market Research

Cord Blood Banking Services MarketAccording to a new market report published by Transparency Market Research, Cord Blood Banking Services Market (Private and Public Cord Blood Banks)  Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019″, the global cord blood banking services market was valued at USD 12.40 billion in 2012 and is expected to grow at a CAGR of 5.6% from 2013 to 2019, to reach an estimated value of USD 15.23 billion in 2019.

Cord blood banking (CBB) is one of the fastest growing segments of the healthcare industry. Factors such as increasing awareness, initiatives taken by governments to regulate the CBB industry, an increasing number of diseases that can be treated using stem cell therapy and growing concerns about developing worldwide cord blood inventory will have an impact on the current model of the cord blood banking industry.

The global cord blood banking services market is segmented on the basis of type of service vendor and geography. Based on service vendor type the cord blood banking market is classified into private cord blood banks and public cord blood banks. The market share of private cord blood banks is larger than the public cord blood banks as private banks charge the service right from the collection of the cord blood followed by storage and processing charges, spends more on advertising and incentives as compared to public banks. It is expected that the global market for private banks will reach USD 11.58 billion in 2019 with the market growing at CAGR of 1.9% from 2013 to 2019. The shift from storing cord blood in private banks to public banks is growing the market share of public cord blood banks globally.

The United States, and some of the European countries such as the U.K. and Spain, are leading in cord blood banking services. Asian countries like China and India are emerging markets with higher population growth rate. UAE, Qatar and Saudi Arabia are some of the lucrative markets in RoW.

North America currently dominates the market but in future developing countries in Asia will lead the market. Growth drivers in the North American market are increasing awareness about the cord blood banking services, stem cell therapy and affordable cost.

Cord Blood Banking Services Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Some of the key market players operating in this market include Cord Blood America, Inc., NeoStem, Inc., Cryo-Cell International, Inc., Cord Blood Registry Systems, Inc. and China Cord Blood Corporation.

The global cord blood banking services market is segmented as follows:

  • Based on Type of Service Vendor
    • Private cord blood banks
    • Public cord blood banks
  • Based on Geography
    • North America
      • United States
      • Canada
    • Europe
      • UK
      • Spain
      • France
      • Germany
      • Italy
      • Belgium
    • Asia-Pacific
      • India
      • China
      • Japan
      • Australia
      • New Zealand
      • Philippines
    • Rest of the World
      • Brazil
      • Argentina
      • Middle Eastern Countries
      • Russia

Browse more reports: Transparency Market Research

Transparency Market Research: Drugs Abuse Testing Market New Analysis Report

Drugs of Abuse Testing MarketAccording to a new market report published by Transparency Market Research “Drugs of Abuse Testing Market (Sample Based Testing – Urine, Saliva and Hair Onsite and laboratory Testing) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018” the global drugs of abuse testing market was valued at USD 2.6 billion in 2012 and is expected to grow at a CAGR of 4.8% from 2013 to 2018, to reach an estimated value of USD 3.4 billion in 2018.

Browse the full Report with TOChttp://www.transparencymarketresearch.com/drugs-abuse-testing-market.html

In various countries, government rules & regulations are supporting drugs of abuse testing market to grow, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. As a result, this market is expected to grow at a CAGR of about 4.8% during 2013 – 2018.

Some of the key driving factors for the drugs of abuse testing market are global rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns.

North America, including the US has the largest drugs of abuse testing market and is also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and Europe countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market.

Browse full PDF wih TOC: Drugs of Abuse Testing Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only.

Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.

The global drugs of abuse testing market is segmented as follows:

Drugs of Abuse Testing Market, By Sample

  • Urine
  • Saliva
  • Hair

Drugs of Abuse Testing Market, By Types

  • Laboratory Drug Test
  • On-site Screening Test

Drugs of Abuse Testing Market, by Geography

  • North America
  • US
  • Europe
  • UK
  • Germany
  • France
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of the World (RoW)

Ophthalmic Drugs Market is Expected to Reach USD 21.6 Billion Globally in 2018: Transparency Market Research

Ophthalmic Drugs MarketAccording to a new market report published by Transparency Market Research “Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti allergy/ inflammatory/ infective, Retinal Drugs) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018” the global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6 billion in 2018.

Browse the full Report with TOC: http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

Globally, the ophthalmic drugs market is witnessing significant growth due to increasing prevalence of eye disorders such as diabetic retinopathy and macular degeneration. As a result, this market is expected to grow at a CAGR of about 5.2% during 2013 – 2018.

Some of the key driving factors for the ophthalmic drugs market are rising prevalence of global aging population, increasing government initiatives towards healthcare infrastructure in developing countries (such as India and China), technological changes in drug delivery technique, and increasing prevalence of lifestyle associated diseases. However, the market faces some restraints such as lack of awareness among people regarding eye disorders, drying pipeline of ophthalmic drugs, patent expiration of blockbuster ophthalmic drugs and absence of health insurance in developing countries.

download-pdf

North America, including the US has the largest ophthalmic drugs market. Asia is the fastest growing ophthalmic drugs market. Some of the fastest growing markets for ophthalmic drugs are China, India, other countries in South East Asia and the Eastern Mediterranean. As per WHO estimates in 2010, in the next nine years, the number of blind people aged 50 years and above will grow in these regions, thereby increasing the demand for ophthalmic drugs. On the other hand, in developed regions such as North America and Western Europe, rising efforts towards prevention of blindness among the aging population has emerged as a key driver for the market.

Browse full PDF with TOC: Ophthalmic Drugs Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Glaucoma has the largest market share in the ophthalmic drugs market and it is expected to grow at a CAGR of about 4.2% during 2013 – 2018. Various ophthalmic drug companies are increasing their focus on combination therapy, which involves use of more than one medication for specific retinal disorders. Most of these combination therapies are used as first line treatment in patients with high level of intraocular pressure. Combination therapy has various advantages over traditional medication such as reduced frequency of eye drop application, improved patient compliance and efficacy.

Novartis (Alcon) is the leading player in the global ophthalmic drugs market while other major players include Allergan, Santen, Pfizer, Merck and Roche.

The global ophthalmic drugs market is segmented as follows:

Ophthalmic Drugs Market, By Treatment Drugs

  • Dry Eye Drugs
  • Retinal Drugs
  • Anti-inflammatory/allergy/infective Drugs
  • Anti-glaucoma Drugs

Ophthalmic Drugs Market, By Types

  • Prescription Drugs
  • OTC Drugs

Ophthalmic Drugs Market, by Geography

  • North America
  • US
  • Europe
  • Germany
  • UK
  • France
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research